Literature DB >> 9987204

Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap.

P Tibbo1, L Warneke.   

Abstract

OBJECTIVE: To examine the co-existence of obsessive-compulsive disorder (OCD) with schizophrenia in terms of epidemiology and overlapping biologic substrates.
METHODS: Review of the relevant literature.
RESULTS: There appears to be a significant prevalence of OCD in schizophrenia--higher than what would be expected on the basis of calculated comorbidity figures. There is significant overlap in the proposed functional circuits of OCD and schizophrenia, which may lead to co-expression of symptoms. Although there is overlap in neurotransmitter dysfunction, the interactions are complex, especially in regard to the serotonin and dopamine systems.
CONCLUSION: The expression of OCD in schizophrenia is complex but very intriguing. Theoretical hypotheses of the pathology of the 2 disorders now need to be tested in larger controlled trials.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9987204      PMCID: PMC1188973     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  82 in total

1.  OBSESSIONAL NEUROTICS: A LONG-TERM FOLLOW-UP.

Authors:  E KRINGLEN
Journal:  Br J Psychiatry       Date:  1965-08       Impact factor: 9.319

2.  The clinical significance of obsessions in schizophrenia.

Authors:  I ROSEN
Journal:  J Ment Sci       Date:  1957-10

3.  Natural history of obsessional states; a study of 150 cases.

Authors:  J POLLITT
Journal:  Br Med J       Date:  1957-01-26

4.  Addition of fluoxetine to clozapine.

Authors:  S L Cassady; G K Thaker
Journal:  Am J Psychiatry       Date:  1992-09       Impact factor: 18.112

5.  Transition of obsessions into delusions. Evaluation of obsessional phenomena from the prognostic standpoint.

Authors:  A GORDON
Journal:  Am J Psychiatry       Date:  1950-12       Impact factor: 18.112

Review 6.  Neurosurgical treatment of malignant obsessive compulsive disorder.

Authors:  M A Jenike
Journal:  Psychiatr Clin North Am       Date:  1992-12

Review 7.  Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.

Authors:  S R Grimsley; M W Jann
Journal:  Clin Pharm       Date:  1992-11

8.  Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder.

Authors:  L R Baxter; J M Schwartz; K S Bergman; M P Szuba; B H Guze; J C Mazziotta; A Alazraki; C E Selin; H K Ferng; P Munford
Journal:  Arch Gen Psychiatry       Date:  1992-09

9.  Emergence of obsessive compulsive symptoms during treatment with clozapine.

Authors:  R W Baker; K N Chengappa; J W Baird; S Steingard; M A Christ; N R Schooler
Journal:  J Clin Psychiatry       Date:  1992-12       Impact factor: 4.384

10.  Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics.

Authors:  M S Buchsbaum; R J Haier; S G Potkin; K Nuechterlein; H S Bracha; M Katz; J Lohr; J Wu; S Lottenberg; P A Jerabek
Journal:  Arch Gen Psychiatry       Date:  1992-12
View more
  27 in total

Review 1.  Toward an integrative understanding of social phobia.

Authors:  D Li; P Chokka; P Tibbo
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Obsessive-compulsive disorder in the community: 12-month prevalence, comorbidity and impairment.

Authors:  Yuki Adam; Gunther Meinlschmidt; Andrew T Gloster; Roselind Lieb
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-02-02       Impact factor: 4.328

Review 3.  Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature.

Authors:  Trehani M Fonseka; Margaret A Richter; Daniel J Müller
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

4.  Altered Functional Connectivity of the Default Mode Network in Patients With Schizo-obsessive Comorbidity: A Comparison Between Schizophrenia and Obsessive-compulsive Disorder.

Authors:  Yong-Ming Wang; Lai-Quan Zou; Wen-Lan Xie; Zhuo-Ya Yang; Xiong-Zhao Zhu; Eric F C Cheung; Thomas Alrik Sørensen; Arne Møller; Raymond C K Chan
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

5.  Haloperidol induced obsessive compulsive symptom (OCS) in a patient with learning disability and bipolar affective disorder.

Authors:  Inam Ulhaq; Adam Abba-Aji
Journal:  BMJ Case Rep       Date:  2012-03-08

6.  Evidence for inhibitory deficits in the prefrontal cortex in schizophrenia.

Authors:  Natasha Radhu; Luis Garcia Dominguez; Faranak Farzan; Margaret A Richter; Mawahib O Semeralul; Robert Chen; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Brain       Date:  2014-12-17       Impact factor: 13.501

7.  Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS.

Authors:  A Khullar; P Chue; P Tibbo
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

8.  Comparative Analysis of Cognitive Function in Schizophrenia with and without Obsessive Compulsive Disorder.

Authors:  Myung-Ji Lee; Yong-Bum Shin; Young-Kyung Sunwoo; Seung-Ho Jung; Won-Hyoung Kim; Min-Hee Kang; Jeong-Seop Lee; Jae-Nam Bae; Chul-Eung Kim
Journal:  Psychiatry Investig       Date:  2009-11-09       Impact factor: 2.505

9.  Reduced cortical folding of the anterior cingulate cortex in obsessive-compulsive disorder.

Authors:  Geumsook Shim; Wi Hoon Jung; Jung-Seok Choi; Myung Hun Jung; Joon Hwan Jang; Ji-Young Park; Chi-Hoon Choi; Do-Hyung Kang; Jun Soo Kwon
Journal:  J Psychiatry Neurosci       Date:  2009-11       Impact factor: 6.186

10.  Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome.

Authors:  Tara A Niendam; Jodi Berzak; Tyrone D Cannon; Carrie E Bearden
Journal:  Schizophr Res       Date:  2008-12-20       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.